Jun 24, 2026
15 MIN READ

What is in Wegovy Shot? A Detailed Look at the Science and Ingredients

Wegovy's active ingredient is semaglutide, a glucagon-like peptide-1 receptor agonist that signals fullness to your brain. PlexusDx provides compounded semaglutide injections from licensed pharmacies, offering the same mechanism at a lower cost.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 24, 2026
15 MIN READ

what is in wegovy shot? a detailed look at the science and ingredients — PlexusDx GLP-1 education

Last reviewed: June 24, 2026

Last updated: June 24, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Wegovy shots contain semaglutide, a synthetic version of a hormone your body naturally produces called GLP-1. This medication works by activating receptors in your brain that regulate hunger and blood sugar, leading to reduced appetite and slower stomach emptying. Understanding what's actually in these injections helps you make informed decisions about your weight loss treatment options.

The Active Ingredient: Semaglutide Explained

Semaglutide is a modified peptide that mimics glucagon-like peptide-1, a hormone released after eating. In clinical trials, semaglutide demonstrated sustained weight loss, with participants losing an average of 15% of body weight over 68 weeks at therapeutic doses. The medication binds to GLP-1 receptors found throughout your brain, pancreas, and digestive system, triggering multiple pathways that reduce hunger signals and increase feelings of fullness.

Your body's natural GLP-1 is typically broken down within minutes, but semaglutide's chemical structure resists this rapid degradation, extending its effects to a full week per injection. This extended duration is why Wegovy and similar formulations are given once weekly rather than multiple times daily. The peptide's ability to persist in your bloodstream allows for consistent appetite suppression and metabolic support throughout the week.

Excipients and Inactive Ingredients in Semaglutide Injections

Beyond semaglutide itself, injectable formulations contain several excipients that stabilize the medication and make it safe for injection. These include sodium phosphate dibasic, sodium phosphate monobasic, and sodium chloride, which maintain the solution's pH and osmolarity so it matches your body's internal environment. Disodium hydrogen phosphate dihydrate and sodium dihydrogen phosphate dihydrate act as buffers, preventing the semaglutide from breaking down prematurely in the vial.

Water for injection serves as the solvent, while methyl paraben and propyl paraben function as preservatives to prevent bacterial and fungal growth once the vial is opened. The concentration of these excipients is carefully balanced to ensure stability without triggering allergic reactions in most patients. PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies, which maintain strict quality standards for both active and inactive ingredients.

How Semaglutide Works at the Molecular Level

Once injected subcutaneously, semaglutide diffuses into nearby blood vessels and circulates to your brain, particularly the hypothalamus, which controls appetite regulation. The medication binds to GLP-1 receptors on specialized neurons that sense nutrient availability and body energy status. This binding triggers a cascade of signals that suppress hunger hormones like ghrelin while simultaneously boosting satiety signals, fundamentally altering how your brain perceives food need.

Semaglutide also slows gastric emptying—the rate at which food moves from your stomach into your small intestine—creating prolonged sensations of fullness even after small meals. Additionally, the medication improves insulin secretion in response to meals and reduces hepatic glucose production, stabilizing blood sugar levels. These combined effects explain why patients on semaglutide typically consume 300-500 fewer calories daily without consciously restricting food intake.

Compounded vs. Brand-Name Semaglutide: Key Differences

Brand-name Wegovy and compounded semaglutide contain the identical active pharmaceutical ingredient and work through the same biological mechanisms. The primary differences lie in manufacturing oversight, cost, and availability rather than chemical composition or efficacy. PlexusDx partners with licensed 503A compounding pharmacies, which adhere to FDA guidelines and USP standards while operating differently than the large-scale manufacturing facilities that produce brand-name medications.

Compounded semaglutide typically costs significantly less—PlexusDx injections start at $149 per month—because compounding pharmacies avoid the extensive marketing, brand licensing, and middleman distribution costs built into Wegovy's pricing structure. Both formulations require a prescription, weekly injections, and dose escalation protocols, though your dose may need adjustment over time. PlexusDx's pricing remains flat regardless of your dose level, ensuring predictable costs as your treatment progresses.

Understanding Your Individual Response to Semaglutide

Not everyone responds identically to semaglutide because genetic variations in GLP-1 receptor structure and peptide metabolism influence how effectively the medication works in your body. Key genetic variants such as GLP1R rs6923761 and GIPR rs1800437 affect receptor sensitivity, meaning your genetic profile partly determines whether you'll experience robust appetite suppression or a more modest response. PlexusDx offers the Precision Peptide Genetic Test, which analyzes 14 pathways and 49 peptides to predict your likely response patterns to semaglutide and identify whether alternative or combination therapies might suit you better.

Other factors including your baseline metabolic rate, insulin sensitivity, and gastrointestinal function also shape your semaglutide experience. Some patients achieve target weight loss on lower doses, while others require escalation to maximum therapeutic levels. Understanding both your genetic predispositions and metabolic characteristics allows PlexusDx to personalize your treatment plan, maximizing results while minimizing unnecessary dose increases and side effects.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is the semaglutide in Wegovy the same as what PlexusDx offers?

Yes, the active ingredient is identical. PlexusDx compounded semaglutide injections contain the same synthetic GLP-1 receptor agonist as Wegovy, sourced from licensed 503A compounding pharmacies. The key difference is cost—PlexusDx injections start at $149 per month compared to Wegovy's substantially higher retail pricing, with no membership or insurance requirements.

What percentage of body weight do people typically lose on semaglutide?

Clinical trials show average weight loss of 15% of baseline body weight over 68 weeks at therapeutic doses, with some participants achieving 20% or greater loss. Results vary based on genetics, lifestyle adherence, and individual metabolic factors. PlexusDx's Precision Peptide Genetic Test can help predict your likely response trajectory.

Can I be allergic to the inactive ingredients in semaglutide injections?

While rare, some patients experience sensitivity to preservatives like methyl paraben or propyl paraben used in injectable formulations. If you have documented paraben sensitivities, inform PlexusDx during your consultation so alternative options can be discussed. Most patients tolerate these excipients without difficulty since they're used in many other medical products.

How long does semaglutide stay in your system after injection?

Semaglutide has a half-life of approximately 7 days, meaning it takes about one week for your body to eliminate half the injected dose. Because of this extended duration, therapeutic levels build up over the first 4-5 weeks of weekly injections, which is why dose escalation protocols typically advance every month rather than weekly.

Does PlexusDx offer genetic testing to personalize semaglutide dosing?

Yes, PlexusDx offers the Precision Peptide Genetic Test for $99 after your first month of treatment. This test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways to predict your semaglutide response and identify whether combination therapies like tirzepatide might work better for your genetic profile.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves